Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating patients with chronic obstructive pulmonary disease (COPD) …

Inhalation therapy is the mainstay of chronic obstructive pulmonary disease management,
and inhaler selection can have a profound impact on drug delivery and medication …

The aim of this study was to determine prevalence and possible clinical predictors of
suboptimal peak inspiratory flow rate (PIFR) with different dry powder inhalers. PIFR was …

The study aimed to determine the associations of Peak Inspiratory Flow (PIF), inhalation
technique and adherence with health status and exacerbations in participants with COPD …

Abstract Introduction Dry powder inhalers (DPIs), a commonly prescribed inhaler type for
respiratory diseases, require patients to generate sufficient peak inspiratory flow (PIF) to …

Biomarkers in COPD may be clinical (prior exacerbation history), physiologic (FEV 1), or
blood based (eosinophil count or fibrinogen level). Recent interest in using biomarkers to …

Dry powder inhalers (DPIs) are breath actuated, and patients using DPIs need to generate
an optimal inspiratory flow during the inhalation maneuver for effective drug delivery to the …

Older adults have a higher prevalence of chronic obstructive pulmonary disease (COPD),
which will likely increase substantially in the coming decades owing to aging populations …

Purpose A suboptimal peak inspiratory flow (PIF) against a dry powder inhaler (DPI) may
result in ineffective inhalation of medications, which may affect outcomes. The primary …

Optimal delivery of medication via dry powder inhalers, the most commonly prescribed
inhaler type, is dependent on a patient achieving a minimum level of inspiratory flow during …